annotations = {'TB-TB-2018-DAR-PIA.pdf': [],
 'TB-TB-2018-M-P-A.pdf': [146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160],
 'HIV-HIV-2016-Ayles-A Study of the HIV prevention Trials Network.pdf': [],
 'TB-TB-2019-T-A-b.pdf': [304,
 305,
 306,
 307,
 308,
 309,
 310,
 311,
 312,
 313,
 314,
 315,
 316,
 317,
 318,
 319,
 320,
 321,
 322,
 323,
 324,
 325,
 326,
 327,
 328,
 329,
 330,
 331,
 332,
 333,
 334,
 335,
 336,
 337,
 338,
 339,
 340,
 341,
 342,
 343,
 344,
 345,
 346,
 347,
 348,
 349,
 350,
 351,
 352,
 353,
 354,
 355,
 356,
 357,
 358,
 359,
 360,
 361,
 362,
 363,
 364,
 365,
 366,
 367,
 368,
 369,
 370,
 371,
 372,
 373,
 374,
 375,
 376,
 377,
 378,
 379,
 380,
 381,
 382,
 383,
 384,
 385,
 386,
 387,
 388],
 'HIV-HIV-2016-Laufer-Trimethoprim-Sulfamethoxazole-Chloroquine.pdf': [],
 'NTD-Filariasis-2019-Weil-DOLF IDA Papua New Guinea.pdf': [],
 'HIV-HIV-2017-Abrams-IMPAACT P1101.pdf': [],
 'NUT-A-2019-M-T.pdf': [164,
 165,
 166,
 167,
 168,
 169,
 170,
 171,
 172,
 173,
 174,
 175,
 176,
 177,
 178,
 179,
 180,
 181,
 182,
 183,
 184,
 185,
 186,
 187,
 188,
 189,
 190,
 191,
 192,
 193,
 194,
 195],
 'HIV-HIV-2018-IMPAACT-P1112.pdf': [],
 'EDD-rotavirus-2017-Isanaka-ROSE.pdf': [141,
 142,
 143,
 144,
 145,
 146,
 147,
 148,
 149,
 150,
 151,
 152,
 153,
 154,
 155,
 156,
 157,
 158,
 159,
 160,
 161,
 162,
 163,
 164,
 165,
 166,
 167,
 168,
 169,
 170,
 171,
 172,
 173,
 174,
 175,
 176,
 177,
 178,
 179,
 180,
 181,
 182,
 183,
 184,
 185,
 186,
 187,
 188,
 189,
 190,
 191,
 192,
 193,
 194,
 195,
 196,
 197,
 198,
 199,
 200,
 201,
 202,
 203,
 204,
 205,
 206,
 207,
 208,
 209],
'NTD-Y-2019-M-Y.pdf': [51, 52],
'NTD-Chagas-2015-Morillo-BENEFIT.pdf': [59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75],
'MAT-V-2018-R-M.pdf': [150,
 151,
 152,
 153,
 154,
 155,
 156,
 157,
 158,
 159,
 160,
 161,
 162,
 163,
 164,
 165,
 166,
 167,
 168,
 169,
 170,
 171,
 172,
 173,
 174,
 175,
 176,
 177,
 178,
 179,
 180,
 181,
 182,
 183,
 184,
 185,
 186,
 187,
 188,
 189,
 190,
 191,
 192],
'HIV-HIV-2018-GSK1265744.pdf': [53,54,55,56,57],
 "POL-P-2018-O-A-L.pdf": [34,35,36,37],
'MAT-Hypothermia-2018-Hansen-Electricity-free Infant Warmer.pdf': [],
'EDD-T-2019-S-T.pdf': [91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104],
'NTD-Hookwork-2018-Keiser-Efficacy and safety of a single.pdf': [], # There is a single page about statistics but I am not counting this as an SAP.
'TB-TB-2018-Piazza-A Phase 1b, Randomized, Double-blind.pdf': [],
'MAL-Malaria-2019-Llanos-Cuentas-Tafenoquine vs. Primaquine to.pdf': [381, # called the Meta-Analysis Plan
 382,
 383,
 384,
 385,
 386,
 387,
 388,
 389,
 390,
 391,
 392,
 393,
 394,
 395,
 396,
 397,
 398,
 399,
 400,
 401],
 'HIV-HIV-2017-Corey-HVTN703-HPTN081.pdf': [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77], # Called "statistical considerations" here
 'MAL-M-2019-A-S.pdf': [57,
 58,
 59,
 60,
 61,
 62,
 63,
 64,
 65,
 66,
 67,
 68,
 69,
 70,
 71,
 72,
 73,
 74,
 75,
 76,
 77,
 78,
 79,
 80,
 81,
 82,
 83,
 84,
 85,
 86,
 87,
 88,
 89,
 90,
 91],
 'NTD-E-2017-A-A.pdf': [], # has a small section but not counting this as SAP.
  'HIV-HIV-2017-Bekker-HVTN100.pdf': [], #  has a small statistical analysis section but no SAP
  'MAL-Malaria-2019-Tinto-Extension to study MALARIA-055 PRI.pdf': [], # has statistical methods section but no SAP
'NUT-NUT-2019-A-I.pdf': [],
  'HIV-HIV-2018-M-A.pdf': [114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180], # but this is a scanned protocol
 'HIV-HIV-2017-L-I.pdf': [138, 139, 140, 141, 142, 143, 144, 145, 146, 147],
 'TB-TB-2019-M-A.pdf': [109, 110, 111, 112],
 'VAC-G-2016-VAC-G-2016-V.pdf': [35, 36, 37, 38, 39, 40],
 'HIV-HIV-2016-N-S.pdf': [244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357],
  'VAC-Shigellosis-2019-Raqib-Shigella WRSS1 Vaccine trial in Bangladesh.pdf': [],
  'HIV-HIV-2017-Evolocumab-AMG145.pdf': [],
#  'TB-TB-2015-D-A.pdf': [], # Don't include - it's in French
#  'POL-P-2016-G-T.pdf': [],
#  'TB-TB-2019-Suliman-A Phase I_IIa Double-Blind.pdf': [],
#  'MAT-Anemia-2015-Etheredge-Prenatal Iron Supplements Safety and.pdf': [],
#  'HIV-HIV-2016-R-E.pdf': [],
#  'HIV-HIV-2019-H-S.pdf': [],
#  'NTD-Filariasis-2019-Weil-DOLF IDA Haiti.pdf': [],
#  'MAT-MAT-2018-G-F.pdf': [],
#  'EDD-R-2017-G-V.pdf': [],
#  'MAT-HIV-2016-Fowler-PROMISE.pdf': [],
#  'TB-TB-2018-H-A.pdf': [],
#  'HIV-HIV-2016-HVTN114.pdf': [],
#  'HIV-HIV-2018-Long-acting Cabotegravir Plus Long-acting Rilpivirine.pdf': [],
#  'NUT-S-2018-R-S.pdf': [],
#  'VAC-Tdap-2019-Sancovski-A Post-marketing, Observational, Retrospective.pdf': [],
#  'NTD-t-2017-M-E.pdf': [],
#  'HIV-HIV-2018-Lockman-Dolutegravir-Containing versus Efavirenz-Containing Antiretroviral Therapy.pdf': [],
#  'MAL-M-2018-D-C.pdf': [],
#  'NTD-D-2017-S-P.pdf': [],
#  'HIV-HIV-2016-Garrett-HVTN108.pdf': [],
#  'HIV-HIV-2018-Labhardt-CASCADE.pdf': [],
#  'TB-TB-2019-Dawson-A Phase 2 Open‚ÄêLabel Partially .pdf': [],
#  'MAL-MAL-2018-Dorsey-PROMOTE Birth Cohort 1.pdf': [],
#  'PNE-P-2019-C-P.pdf': [],
#  'HIV-HIV-2019-Venter-ADVANCE.pdf': [],
#  'HIV-HIV-2019-K-C.pdf': [],
#  'PNE-Pneumonia-2019-Alexander-LEAP2.pdf': [],
#  'MAT-Cervical Disease-2019-Greene-LEEP.pdf': [],
#  'TB-TB-2018-Churchyard-Bedaquiline-Delamanid.pdf': [],
#  'MAL-Malaria-2019-Foy-RIMDAMAL.pdf': [],
#  'TB-TB-2019-N-S.pdf': [],
#  'NUT-Stunting-2019-Humphrey-SHINE.pdf': [],
#  'PNE-Pneumonia-2018-Keenan-Mortality Reduction After Oral Azithromycin.pdf': [],
#  'EDD-Cholera-2016-Qadri-Shanchol.pdf': [],
#  'TB-TB-2020-John-Stewart-iTIPS.pdf': [],
#  'VAC-Ecoli-2019-Qadri-ETVAX.pdf': [],
#  'HIV-HIV-2018-Havlir-SEARCH.pdf': [],
#  'HIV-HIV-2016-Kurth-High-yield HIV testing, facilitated linkage to care.pdf': [],
#  'HIV-HIV-2017-Corey-HVTN704-HPTN085.pdf': [],
#  'HIV-HIV-2016_Tebas-A5354.pdf': [],
#  'HIV-HIV-2016-Weinberg-NICHP1091.pdf': [],
#  'MAL-Malaria-2016-Valencia-Phase 1 and 2a Clinical.pdf': [],
#  'NTD-Filariasis-2019-Weil-DOLF IDA Indonesia.pdf': [],
#  'VAC-M-2015-L-W.pdf': []
              }
